About this episode
Tickets for our live show in New York are on sale now! Get yours here.
Peptides are a huge part of the wellness craze that’s sweeping social media. Demand for restricted peptides has fueled an online gray market for injections promising youth, beauty and strength. Businesses are racing—and taking risks—to get in on the craze. WSJ's Sara Ashley O’Brien explores the burgeoning peptide market and how a recent FDA hearing could signal things are only just getting started. Jessica Mendoza hosts.
Further Listening:
- Trillion Dollar Shot
- The FDA Boss on the Agency's MAHA Makeover
Sign up for WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Get every episode summarized
Each time The Journal. publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Journal.
The MAHA Shake-Up at Steak ‘n Shake
The Journal.
Sep 11, 202619:58completed
What Happened to the Affordable Car?
The Journal.
Sep 10, 202619:09completed
A Data Center Offered $26 Million for Her Land. She Said No.
The Journal.
Sep 9, 202629:22completed
AI Companies Are Buying and Destroying Used Books
The Journal.
Sep 8, 202620:43completed